{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:21:45Z","timestamp":1794986505021,"version":"4.9.1"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Vasoplegia is a form of distributive shock that commonly occurs after cardiac surgery involving cardiopulmonary bypass. Although a formal definition does not exist, it is generally characterized by low systemic vascular resistance with a maintained or elevated cardiac index that tends to be resistant to treatment with fluid or vasopressor. Postoperative vasoplegia in cardiac surgery patients is associated with increased morbidity and mortality. This article reviews the current understanding of the pathophysiology of vasoplegia in cardiac surgery, including risk factors for its development, and evolving strategies for prediction, diagnosis, and treatment. Prominent preoperative risk factors include patient demographics (older age, male sex, elevated body mass index), comorbid conditions (heart failure with reduced ejection fraction, chronic kidney disease, anemia, infective endocarditis, hemodynamic instability, thyroid dysfunction, diabetes mellitus, tobacco use), medications (renin-angiotensin-aldosterone axis blockers, calcium channel blockers, beta-blockers, inotropes, antiplatelets and anticoagulants, amiodarone, diuretics, anesthetic agents), and the type of surgical procedure performed. Prominent intraoperative risk factors include the use of cardiopulmonary bypass, blood product transfusion, and poor temperature control. Multiple biomarkers and dynamic monitoring systems are being studied as predictors for the development of vasoplegia. An overview of available treatments is presented along with up-to-date evidence supporting their use in multimodal vasopressor regimens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000008086","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:01:58Z","timestamp":1781107318000},"page":"1049-1061","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Causes, Predictors, and Treatment of Vasoplegia in Cardiac Surgery: A Narrative Review"],"prefix":"10.1213","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7052-3145","authenticated-orcid":false,"given":"Ahmed S.","family":"Awad","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Cooper University Health Care, Camden, New Jersey"},{"name":"Cooper Medical School of Rowan University, Camden, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6760-2084","authenticated-orcid":false,"given":"Adam S.","family":"Mangold","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Cooper University Health Care, Camden, New Jersey"},{"name":"Cooper Medical School of Rowan University, Camden, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8592-1252","authenticated-orcid":false,"given":"Ana","family":"Ainechi","sequence":"additional","affiliation":[{"name":"Cooper Medical School of Rowan University, Camden, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-9816","authenticated-orcid":false,"given":"Ludmil V.","family":"Mitrev","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Cooper University Health Care, Camden, New Jersey"},{"name":"Cooper Medical School of Rowan University, Camden, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"2460770","DOI":"10.1080\/07853890.2025.2460770","article-title":"The mystery of methylene blue and its role in managing post-cardiac surgery vasoplegic shock.","volume":"57","author":"Elbayomi","year":"2025","journal-title":"Ann Med"},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1053\/j.jvca.2025.02.047","article-title":"Vasoplegic syndrome in cardiac surgery: a narrative review of etiologic mechanisms and therapeutic options.","volume":"39","author":"Polyak","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R3-20261020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14797\/mdcvj.1245","article-title":"Vasoplegia: a review.","volume":"19","author":"Ratnani","year":"2023","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy.","volume":"32","author":"Shaefi","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.medin.2024.03.005","article-title":"Factors associated with vasoplegic shock in the postoperative period of cardiac surgery and influence on morbidity and mortality of the use of arginine vasopressin as rescue therapy.","volume":"48","author":"Barrera S\u00e1nchez","year":"2024","journal-title":"Med Intensiva (Engl Ed)"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1213\/ANE.0000000000001045","article-title":"Methylene blue: magic bullet for vasoplegia?","volume":"122","author":"Hosseinian","year":"2016","journal-title":"Anesth Analg"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/eurasianjmed.2022.20394","article-title":"Vasoplegia: mechanism and management following cardiopulmonary bypass.","volume":"54","author":"Muhammad","year":"2022","journal-title":"Eurasian J Med"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13019-019-1014-8","article-title":"Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational study.","volume":"14","author":"van Vessem","year":"2019","journal-title":"J Cardiothorac Surg"},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11886-021-01534-y","article-title":"Vasoplegia from continuous flow left ventricular assist devices.","volume":"23","author":"Sathianathan","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aan.2022.07.010","article-title":"Updates in THE MANAGEMENT OF PERIOPERATIVE VASOPLEGIC SYNDROme.","volume":"40","author":"Brennan","year":"2022","journal-title":"Adv Anesth"},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/02676591231215920","article-title":"Angiotensin-II for vasoplegia following cardiac surgery.","volume":"39","author":"Johnson","year":"2024","journal-title":"Perfusion"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ccc.2023.06.002","article-title":"Management of vasoplegic shock in the cardiovascular intensive care unit after cardiac surgery.","volume":"40","author":"Suero","year":"2024","journal-title":"Crit Care Clin"},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1010-7940(02)00734-0","article-title":"Vasoplegic syndrome after off-pump coronary artery bypass surgery.","volume":"23","author":"Gomes","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"R15-20261020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.jvca.2025.02.027","article-title":"Vasoplegia in cardiac surgery: a systematic review and meta-analysis of current definitions and their influence on clinical outcomes.","volume":"39","author":"Papazisi","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R16-20261020","first-page":"532","article-title":"Incidence and predictors of vasoplegia after heart failure surgery.","volume":"51","author":"van Vessem","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"R17-20261020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00540-019-02727-0","article-title":"Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome.","volume":"34","author":"Suga","year":"2020","journal-title":"J Anesth"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"e13994","DOI":"10.1111\/ctr.13994","article-title":"Incidence of vasoplegic syndrome after cardiac transplantation in patients treated with sacubitril\/valsartan.","volume":"34","author":"Dom\u00ednguez","year":"2020","journal-title":"Clin Transplant"},{"key":"R19-20261020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cardfail.2021.11.020","article-title":"Vasoplegia following orthotopic heart transplantation: prevalence, predictors and clinical outcomes.","volume":"28","author":"Batchelor","year":"2022","journal-title":"J Card Fail"},{"key":"R20-20261020","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/jocs.15663","article-title":"Risk factors for vasoplegia after coronary artery bypass and valve surgery.","volume":"36","author":"Bastopcu","year":"2021","journal-title":"J Card Surg"},{"key":"R21-20261020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12872-024-03938-4","article-title":"The role of hemoadsorption in cardiac surgery - a systematic review.","volume":"24","author":"Matejic-Spasic","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R22-20261020","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.3390\/jcm11195523","article-title":"Vasoplegic syndrome after cardiac surgery for infective endocarditis.","volume":"11","author":"Lim","year":"2022","journal-title":"J Clin Med"},{"key":"R23-20261020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/ALN.0000000000004130","article-title":"Anesthesia considerations in infective endocarditis.","volume":"136","author":"Hermanns","year":"2022","journal-title":"Anesthesiology"},{"key":"R24-20261020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.redar.2018.12.011","article-title":"Vasoplegic syndrome in cardiac surgery: definitions, pathophysiology, diagnostic approach and management.","volume":"66","author":"Orozco Vinasco","year":"2019","journal-title":"Rev Esp Anestesiol Reanim (Engl Ed)"},{"key":"R25-20261020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.healun.2024.02.1458","article-title":"Vasoplegic syndrome during heart transplantation: a systematic review and meta-analysis.","volume":"43","author":"Kumar","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R26-20261020","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1053\/j.jvca.2019.06.011","article-title":"Vasoplegia after restrictive mitral annuloplasty for functional mitral regurgitation in patients with heart failure.","volume":"33","author":"van Vessem","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R27-20261020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.jvca.2022.09.083","article-title":"Review of postoperative care for heart transplant recipients.","volume":"37","author":"Hwang","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R28-20261020","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/jocs.15805","article-title":"Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome-oriented therapeutic management.","volume":"36","author":"Datt","year":"2021","journal-title":"J Card Surg"},{"key":"R29-20261020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival.","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"R30-20261020","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.athoracsur.2011.04.020","article-title":"Transfusion increases the risk for vasoplegia after cardiac operations.","volume":"92","author":"Alfirevic","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R31-20261020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery.","volume":"65","author":"Tsiouris","year":"2017","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R32-20261020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1053\/j.jvca.2020.01.058","article-title":"Severe vasoplegic shock during coronary artery bypass surgery: therapeutic challenges and dilemmas in hemodynamic rescue.","volume":"34","author":"Shah","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R33-20261020","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2017.09.039","article-title":"Characterizing predictors and severity of vasoplegia syndrome after heart transplantation.","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R34-20261020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/ANE.0000000000006839","article-title":"A pilot study of renin-guided angiotensin-ii infusion to reduce kidney stress after cardiac surgery.","volume":"139","author":"Sadjadi","year":"2024","journal-title":"Anesth Analg"},{"key":"R35-20261020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1213\/ANE.0000000000007779","article-title":"The renin-angiotensin-aldosterone system in cardiac surgery and angiotensin ii therapy for vasoplegia.","volume":"142","author":"Zarbock","year":"2026","journal-title":"Anesth Analg"},{"key":"R36-20261020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2023.06.056","article-title":"Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial.","volume":"131","author":"Coulson","year":"2023","journal-title":"Br J Anaesth"},{"key":"R37-20261020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.jvca.2022.11.019","article-title":"Plasma renin activity increases with cardiopulmonary bypass and is associated with vasoplegia after cardiac surgery.","volume":"37","author":"Montgomery","year":"2023","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R38-20261020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin ii and renin kinetics in patients after cardiac surgery.","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"R39-20261020","doi-asserted-by":"crossref","first-page":"e009917","DOI":"10.1161\/JAHA.118.009917","article-title":"Comparison of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker management strategies before cardiac surgery: a pilot randomized controlled registry trial.","volume":"7","author":"van Diepen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R40-20261020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4330\/wjc.v14.i4.250","article-title":"Effect of preoperative renin-angiotensin system blockade on vasoplegia after cardiac surgery: a systematic review with meta-analysis.","volume":"14","author":"Noubiap","year":"2022","journal-title":"World J Cardiol"},{"key":"R41-20261020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2011.10.010","article-title":"Pre-operative risk factors and clinical outcomes associated with vasoplegia in recipients of orthotopic heart transplantation in the contemporary era.","volume":"31","author":"Patarroyo","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R42-20261020","doi-asserted-by":"crossref","first-page":"20343","DOI":"10.1038\/s41598-019-56831-y","article-title":"Levosimendan and systemic vascular resistance in cardiac surgery patients: a systematic review and meta-analysis.","volume":"9","author":"Terbeck","year":"2019","journal-title":"Sci Rep"},{"key":"R43-20261020","doi-asserted-by":"crossref","first-page":"e013108","DOI":"10.1161\/JAHA.119.013108","article-title":"Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices.","volume":"8","author":"Asleh","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R44-20261020","first-page":"551","article-title":"Impact of mechanical circulatory support on posttransplant outcomes.","volume":"36","author":"Dardas","year":"2018","journal-title":"Cardiol Clin"},{"key":"R45-20261020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0267659121989229","article-title":"Vasoplegia in patients following ventricular assist device explant and heart transplantation.","volume":"37","author":"Emmanuel","year":"2022","journal-title":"Perfusion"},{"key":"R46-20261020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12871-018-0645-y","article-title":"Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors.","volume":"18","author":"de Waal","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"R47-20261020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MAT.0000000000000623","article-title":"Incidence and impact of on-cardiopulmonary bypass vasoplegia during heart transplantation.","volume":"64","author":"Truby","year":"2018","journal-title":"ASAIO J"},{"key":"R48-20261020","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.amjcard.2018.08.035","article-title":"Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation.","volume":"122","author":"Raza","year":"2018","journal-title":"Am J Cardiol"},{"key":"R49-20261020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: a meta-analysis.","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R50-20261020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/aca.aca_54_21","article-title":"VASOplegia is Predicted by Preoperative Platelet-LEucocyte conGlomerate Indices in Cardiac Surgery (VASOPLEGICS): a retrospective single-center study.","volume":"25","author":"Magoon","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"R51-20261020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s40618-020-01465-5","article-title":"Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.","volume":"44","author":"Pasero","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"R52-20261020","first-page":"565","article-title":"Postoperative serum levels of Endocan are associated with the duration of norepinephrine support after coronary artery bypass surgery.","volume":"37","author":"Bougl\u00e9","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R53-20261020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/cclm-2023-0511","article-title":"Bioactive adrenomedullin (bio-ADM) is associated with endothelial dysfunction in infants and children with complex congenital heart disease undergoing open-heart surgery on cardiopulmonary bypass.","volume":"62","author":"Schaefer","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"R54-20261020","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/j.jvca.2019.09.004","article-title":"Vasoplegia after cardiac surgery is associated with endothelial glycocalyx alterations.","volume":"34","author":"Abou-Arab","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R55-20261020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II.","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"R56-20261020","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/j.jvca.2023.12.016","article-title":"Adverse clinical effects associated with non-catecholamine pharmacologic agents for treatment of vasoplegic syndrome in adult cardiac surgery.","volume":"38","author":"Hwang","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R57-20261020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial.","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"R58-20261020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future.","volume":"22","author":"Levy","year":"2018","journal-title":"Crit Care"},{"key":"R59-20261020","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1053\/j.jvca.2018.04.006","article-title":"Vasopressin in Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.","volume":"32","author":"D\u00fcnser","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R60-20261020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock.","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R61-20261020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin ii is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a post-hoc analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study.","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R62-20261020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10557-020-07098-3","article-title":"The use of angiotensin ii for the treatment of post-cardiopulmonary bypass vasoplegia.","volume":"36","author":"Papazisi","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"R63-20261020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13019-021-01579-8","article-title":"The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.","volume":"16","author":"Petermichl","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"R64-20261020","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s12630-019-01449-x","article-title":"Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.","volume":"66","author":"Charles","year":"2019","journal-title":"Can J Anaesth"},{"key":"R65-20261020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.jvca.2019.08.034","article-title":"A pilot, double-blind, randomized, controlled trial of high-dose intravenous vitamin C for vasoplegia after cardiac surgery.","volume":"34","author":"Yanase","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:00:39Z","timestamp":1792537239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000008086","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}